Schedule 13G ownership disclosure

ENTASIS THERAPEUTICS HLDGS I

Security class unavailable · CUSIP: 293614103

Event date: 2018-09-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
16.6900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-18-289658
Form type
SC 13G
Filer
Entasis Therapeutics Holdings Inc.
CIK
CIK 1724344
Filed
Oct 01, 2018
Reporting period
Sep 28, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub